BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9029504)

  • 1. Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes.
    Ingenhoven N; Beck-Sickinger AG
    J Recept Signal Transduct Res; 1997; 17(1-3):407-18. PubMed ID: 9029504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, receptor binding, and crosslinking of photoactive analogues of neuropeptide Y.
    Beck-Sickinger AG; Wieland HA; Brunner J
    J Recept Signal Transduct Res; 1995; 15(1-4):473-85. PubMed ID: 8903958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the human neuropeptide Y Y2-receptor.
    Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
    Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.
    Khan IU; Reppich R; Beck-Sickinger AG
    Biopolymers; 2007; 88(2):182-9. PubMed ID: 17206650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
    Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
    J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression cloning of a human brain neuropeptide Y Y2 receptor.
    Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
    Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes.
    Koglin N; Beck-Sickinger AG
    Neuropeptides; 2004 Aug; 38(4):153-61. PubMed ID: 15337368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of high-potency neuropeptide Y analogues through systematic lactamization.
    Kirby DA; Britton KT; Aubert ML; Rivier JE
    J Med Chem; 1997 Jan; 40(2):210-5. PubMed ID: 9003519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First selective agonist of the neuropeptide Y1-receptor with reduced size.
    Zwanziger D; Böhme I; Lindner D; Beck-Sickinger AG
    J Pept Sci; 2009 Dec; 15(12):856-66. PubMed ID: 19890892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA; Hughes BA; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors.
    Grandt D; Schimiczek M; Rascher W; Feth F; Shively J; Lee TD; Davis MT; Reeve JR; Michel MC
    Regul Pept; 1996 Nov; 67(1):33-7. PubMed ID: 8952003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
    Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated, branched, and/or cyclic analogues of neuropeptide Y: importance of the pancreatic peptide fold in the design of specific Y2 receptor ligands.
    Reymond MT; Delmas L; Koerber SC; Brown MR; Rivier JE
    J Med Chem; 1992 Oct; 35(20):3653-9. PubMed ID: 1433176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
    Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
    J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel analogues of neuropeptide Y with a preference for the Y1-receptor.
    Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG
    Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.